Edgewise Therapeutics, Inc. 8-K

What Happened

• Edgewise Therapeutics, Inc. (EWTX) announced its financial results for the quarter ended March 31, 2026 by issuing a press release on May 7, 2026. The press release text is attached to the 8-K as Exhibit 99.1 and is incorporated by reference into the filing (Item 2.02).

Key Details

• Filing date: May 7, 2026 (8-K furnished under Item 2.02).
• Quarter covered: First quarter ended March 31, 2026.
• Exhibit attached: Press release included as Exhibit 99.1.
• Legal note (Item 9.01): The press release and exhibits are furnished, not “filed” for purposes of Section 18 of the Exchange Act and are not automatically incorporated by reference into other filings unless expressly stated.

Why It Matters

• This 8-K signals that Edgewise has released its quarterly earnings/financial results; investors should read the attached press release for specific figures on revenue, expenses, cash position, and operational updates.
• Because the release is furnished (not filed), it carries limited Section 18 liability and will not be automatically incorporated into future SEC filings unless the company explicitly does so.